Stock Taper
SCREENER COMPARE ANY 2 STOCKS
BLCO
BAUSCH + LOMB CORPORATION
NYSE
$17.15
▲ UP 0.12% (0.02)

KEY STATISTICS

Market Cap$6.13 B
52w High$18.91
52w Low$13.77
Dividend Yield—
Frequency—
P/E26.38
Volume403.11K
Shares Out.357.17M

COMPANY

LEADERSHIP

Brenton L. Saunders
CHIEF EXECUTIVE
Brenton L. Saunders

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 6, 2022
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
13,000

PRICE TARGET

Target High$23.00
Target Low$16.00
Target Median$19.00
Target Consensus$19.25

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$1.37B
NOV
4
WED

PRICE

$17.15 ▲ UP 0.12% (+$0.02)
$17.00$17.10$17.20$17.309:36 AM10:40 AM11:44 AM12:47 PM1:51 PM2:55 PM3:59 PM17.15

About Bausch + Lomb Corporation

https://www.bausch.com ↗

Bausch + Lomb is a global eye health company offering contact lenses, eye care products, pharmaceuticals, and surgical solutions for various eye conditions across three segments.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT BAUSCH + LOMB CORPORATION IS KNOWN FOR

MIEBO™ (perfluorohexyloctane ophthalmic solution)
MIEBO™ (perfluorohexyloctane ophthalmic solution)

A prescription eye drop FDA-approved to treat dry eye disease by directly targeting tear evaporation, a leading cause, marking a significant recent innovation for the company.

COMPETITORS

COMPETITOR
ALC COMPARE
COO COMPARE
GKOS COMPARE
JNJ COMPARE
STAA COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Device Products$484M $518M ▲$480M ▼$524M ▲
Over the Counter Products$454M $489M ▲$444M ▼$497M ▲
Pharmaceutical Products$280M $319M ▲$266M ▼$300M ▲
Branded and Other Generic Products$59M $72M ▲$49M ▼$68M ▲
Other Revenues$4M $7M ▲$5M ▼$5M

Revenue by Geography

MapREGIONQ1-2024Q2-2024Q3-2024Q4-2024
United States and Puerto Rico$537M $610M ▲$609M ▼$657M ▲
Other Countries$166M $175M ▲$174M ▼$244M ▲
CHINA$77M $93M ▲$92M ▼$96M ▲
FRANCE$60M $64M ▲$52M ▼$51M ▼
JAPAN$42M $43M ▲$45M ▲$50M ▲
CANADA$28M $32M ▲$33M ▲$34M ▲
GERMANY$42M $40M ▼$38M ▼$32M ▼
SPAIN$21M $25M ▲$20M ▼$26M ▲
ITALY$23M $23M $22M ▼$23M ▲
MEXICO$17M $20M ▲$18M ▼$20M ▲
POLAND$15M $18M ▲$17M ▼$15M ▼
KOREA REPUBLIC OF$12M $11M ▼$12M ▲—

ETFS HOLDING THIS STOCK

ETFS HOLDING
7
LISTED HERE
5
RANKED BY POSITION SIZE
MGMT
1.41% · 142.6K
DFAX
0.00% · 15.2K
PDN
0.04% · 9.3K
GVLU
0.04% · 6.1K
BKSE
0.03% · 1.7K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
8.11%
HOLDERS
134
TOP 12 OF 134 · RANKED BY POSITION SIZE
Deutsche Bank AG\
3.5M sh · $56.1M
Icahn Carl C
3.5M sh · $55.65M
Oaktree Capital Management LP
3.4M sh · $57.78M
D. E. Shaw & Co., Inc.
3.2M sh · $50.1M
Goldentree Asset Management LP
2.7M sh · $42.21M
Silver Point Capital L.P.
2.6M sh · $43.81M
Davidson Kempner Capital Management LP
2.2M sh · $34.97M
Caspian Capital LP
2.0M sh · $31.78M
Glenview Capital Management, LLC
1.9M sh · $30.38M
Fmr LLC
1.6M sh · $23.51M
Price T Rowe Associates Inc /Md/
1.3M sh · $21.53M
Nomura Holdings Inc
1.3M sh · $19.97M

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book4
Overall Score1

INSIDER TRADES

★
DIRECTOR:
Trebbi Barbara
— · —
2026-08-05
★
DIRECTOR
Chersi Robert J
Purchase · 11.8K shares
2026-08-12
★
DIRECTOR:
Chersi Robert J
— · —
2026-08-05
★
DIRECTOR:
PAUL LAURENCE E
— · —
2026-08-05

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
EQUAL WEIGHT 2
OUTPERFORM 2
IN LINE 1
HOLD 1
OVERWEIGHT 1
NEUTRAL 1
11 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY UBS BUY Evercore ISI Group IN LINE Barclays EQUAL WEIGHT Citigroup BUY Stifel HOLD Wells Fargo EQUAL WEIGHT Morgan Stanley OVERWEIGHT

SECTORS PEERS

PEERPRICE
ARWR$84.91COMPARE
GKOS$179.87COMPARE
PCVX$59.84COMPARE
TGTX$53.93COMPARE
OSCR$30.47COMPARE
TFX$139.67COMPARE
PTCT$70.09COMPARE
CRSP$57.72COMPARE